Cite
APA Citation
Braud, V. M., Biton, J., Becht, E., Knockaert, S., Mansuet-Lupo, A., Cosson, E., Damotte, D., Alifano, M., Validire, P., Anjuère, F., Cremer, I., Girard, N., Gossot, D., Seguin-Givelet, A., Dieu-Nosjean, M., & Germain, C. (2018). expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcome. Oncoimmunology, 7, . http://access.bl.uk/ark:/81055/vdc_100059682821.0x000008